Aino Health AB (publ) (STO:AINO)
0.1600
0.00 (0.00%)
At close: Mar 3, 2026
Aino Health AB Revenue
In the year 2025, Aino Health AB had annual revenue of 26.11M SEK with 9.07% growth. Aino Health AB had revenue of 5.43M in the quarter ending December 31, 2025, a decrease of -9.55%.
Revenue
26.11M
Revenue Growth
+9.07%
P/S Ratio
1.25
Revenue / Employee
1.37M
Employees
19
Market Cap
32.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.11M | 2.17M | 9.07% |
| Dec 31, 2024 | 23.94M | 21.00K | 0.09% |
| Dec 31, 2023 | 23.92M | 4.01M | 20.15% |
| Dec 31, 2022 | 19.91M | -3.14M | -13.61% |
| Dec 31, 2021 | 23.04M | -2.39M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Medicover AB | 25.74B |
| Sectra AB | 3.47B |
| Newbury Pharmaceuticals AB | 36.76M |
| Nanologica AB | 21.05M |
| 2cureX AB | 1.98M |
| SpectraCure AB | 1.11M |